Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Faderl

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Leukemia|October 22, 2005
The evolving role of alemtuzumab in management of patients with CLLS Faderl, S Coutré, J C Byrd, et al.
Cancer|November 7, 2000
The prognostic significance of p16(INK4a)/p14(ARF) locus deletion and MDM-2 protein expression in adult acute myelogenous leukemiaS Faderl, H M Kantarjian, E Estey, et al.
Leukemia|November 9, 2012
Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantationY Chen, H Kantarjian, S Pierce, et al.
Leukemia|May 24, 2003
Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapyA-M Tsimberidou, H M Kantarjian, E Estey, et al.
Leukemia|September 11, 2009
Adult acute erythroleukemia: an analysis of 91 patients treated at a single institutionF P S Santos, S Faderl, G Garcia-Manero, et al.
Investigational New Drugs|April 16, 2011
Phase I/II multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4877 in patients with refractory acute myeloid leukemiaH M Kantarjian, S Padmanabhan, W Stock, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Leukemia|October 22, 2005
The evolving role of alemtuzumab in management of patients with CLLS Faderl, S Coutré, J C Byrd, et al.
Cancer|November 7, 2000
The prognostic significance of p16(INK4a)/p14(ARF) locus deletion and MDM-2 protein expression in adult acute myelogenous leukemiaS Faderl, H M Kantarjian, E Estey, et al.
Leukemia|November 9, 2012
Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantationY Chen, H Kantarjian, S Pierce, et al.
Leukemia|May 24, 2003
Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapyA-M Tsimberidou, H M Kantarjian, E Estey, et al.
Leukemia|September 11, 2009
Adult acute erythroleukemia: an analysis of 91 patients treated at a single institutionF P S Santos, S Faderl, G Garcia-Manero, et al.
Investigational New Drugs|April 16, 2011
Phase I/II multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4877 in patients with refractory acute myeloid leukemiaH M Kantarjian, S Padmanabhan, W Stock, et al.
Pageof 4